ANDE News Alert The Andersons (ANDE) 54.12 11/13/2014 17:15:

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 6:15 PM

The Andersons (ANDE) 54.12 $ANDE

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.63 (-0.32), PRSC: 36.49 (-1.02), FNGN: 32.36 (+0.08), LACO: 7.11 (+0.04), MSON: 11.83 (-0.17), SLXP: 96.99 (+1.44), FNHC: 25.05 (-0.73), MDRX: 12.46 (+0.51), PCMI: 8.94 (+0.14), UBNT: 28.72 (-0.28), PFMT: 6.85 (-0.07), ICPT: 158.86 (-4.10), ANDE: 54.12 (-0.81), ACTA: 16.71 (-0.36)

Andersons (ANDE) Plunges as Q3 Earnings Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 3:20PM CST
The Andersons Inc. (ANDE) plunged 18% on reporting a 3% decline in Q3 earnings to 59 cents per share, way short of the Zacks Consensus Estimate of 76 cents.
BG: 88.75 (+0.24), CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

MRC Global (MRC) Beats Q3 Earnings on Record Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:30PM CST
MRC Global Inc. (MRC) reported improved results for the third quarter of 2014, beating the Zacks Consensus Estimate for both revenues and earnings.
AA: 16.74 (-0.14), MRC: 21.55 (-0.14), ANDE: 54.12 (-0.81), MMP: 84.56 (-0.91)

Andersons (ANDE) Is Today's Dead Cat Bounce Stock
at The Street - Fri Nov 07, 9:23AM CST
Trade-Ideas LLC identified Andersons (ANDE) as a "dead cat bounce" (down big yesterday but up big today) candidate
ANDE: 54.12 (-0.81)

The Andersons' (ANDE) CEO Mike Anderson on Q2 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 11:32PM CST

ANDE: 54.12 (-0.81)

Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 11:47AM CST

SWIR: 38.96 (+1.66), PERI: 5.79 (-0.22), RMGN: 1.09 (-0.03), WWWW: 16.29 (+0.28), ASTI: 2.11 (+0.09), GNW: 9.30 (+0.50), SNMX: 5.61 (-0.23), ALXA: 1.60 (unch), PLUS: 67.25 (-1.98), PPO: 52.91 (+0.12), NSM: 27.25 (-0.26), AEZS: 0.59 (-0.02), WAC: 16.58 (-0.26), KATE: 28.80 (-0.38), CGG: 8.69 (+0.10), ANDE: 54.12 (-0.81), ENG: 1.89 (-0.01), PLNR: 6.67 (-0.48), ALG: 44.79 (-2.72), SZYM: 3.44 (-0.08)

Cosan Q3 Earnings Fall on Weak Revenues and Forex Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:50AM CST
Cosan Limited (CZZ) failed to gain momentum in third-quarter 2014, posting weaker year-over-year results. Net income plummeted approximately 92.6% to R$15.2 million (US$6.7 million) from R$205.9 million (US$90.3 million) in the year-ago quarter.
CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), PEG: 39.28 (-0.44), ANDE: 54.12 (-0.81)

Andersons misses Street 3Q forecasts
Automated Insights - Wed Nov 05, 6:31PM CST
MAUMEE, Ohio (AP) _ The Andersons Inc. (ANDE) on Wednesday reported third-quarter profit of $16.8 million.
ANDE: 54.12 (-0.81)

Andersons misses by $0.17, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:26PM CST

ANDE: 54.12 (-0.81)

The Andersons, Inc. Reports Third Quarter Results
CNW Group - Wed Nov 05, 5:00PM CST
The Andersons, Inc. (Nasdaq: ANDE) today announces financial results for the third quarter ended September 30, 2014.
ANDE: 54.12 (-0.81)

The Andersons (ANDE) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:55AM CST

ANDE: 54.12 (-0.81)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:35PM CST

CXO: 114.97 (-0.56), CODI: 17.06 (-0.11), EXXI: 6.84 (-0.13), JCOM: 55.33 (-0.68), ATSG: 8.32 (-0.12), GPOR: 51.56 (-1.52), ENS: 59.88 (-0.23), ECYT: 6.33 (-0.15), ALNY: 99.33 (-0.52), KGC: 2.52 (+0.06), GSM: 18.00 (-0.78), BKD: 33.07 (+0.19), DK: 29.79 (-1.67), AR: 53.18 (-2.33), IL: 9.57 (+0.01), DVR: 0.14 (-0.08), IO: 2.58 (-0.13), DEPO: 14.78 (+0.13), ETE: 60.92 (-1.03), AVG: 19.27 (-0.21), CSOD: 28.55 (+0.14), GNW: 9.30 (+0.50), ECOL: 42.03 (-2.35), BWC: 30.20 (-0.23), CPE: 6.04 (-0.19), FNV: 50.18 (-0.89), CTL: 40.92 (+0.42), ASH: 112.85 (-0.06), ENSG: 40.53 (-0.17), CLR: 52.60 (-1.67), ACAS: 15.25 (-0.05), G: 17.81 (-0.10), BREW: 13.72 (+0.08), AWK: 51.87 (-0.48), CVG: 21.25 (-0.14), AREX: 11.46 (-0.48), HTCH: 3.57 (-0.13), ETP: 63.63 (-0.91), ABTL: 10.72 (-0.57), FMI: 24.95 (-0.15), DPM: 51.23 (-0.62), BCOR: 14.47 (-0.12), CDE: 3.80 (-0.05), DRYS: 1.41 (-0.02), KW: 26.99 (-0.40), BALT: 3.16 (-0.18), ATO: 54.51 (+0.61), EXAR: 8.75 (-0.12), ACLS: 2.15 (+0.01), INWK: 7.48 (-0.28), ALSK: 1.35 (-0.03), CF: 267.12 (+0.74), EFC: 21.75 (unch), BIOS: 5.86 (+0.09), DYN: 33.22 (-0.92), DATA: 82.59 (-0.86), ANDE: 54.12 (-0.81), HOLX: 26.52 (-0.03), CBS: 51.87 (+0.30)

Andersons Buys 2 Grain Companies to Expand Corn Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:15PM CDT
Andersons (ANDE) has acquired the assets of United Grain and Keller Grain.
BG: 88.75 (+0.24), CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

Dividend Contenders: 34 Increases Expected By December 31
David Fish - at Seeking Alpha - Sat Oct 18, 5:44PM CDT

CASS: 49.03 (-0.40), MATW: 45.95 (-0.17), SEIC: 39.57 (+0.10), SFG: 68.63 (+0.06), NKE: 96.12 (+0.31), NKSH: 30.40 (-1.29), MDU: 25.00 (-0.42), SJI: 57.19 (-0.87), AEL: 27.11 (+0.26), MSM: 83.74 (-0.77), UMBF: 59.59 (-0.89), AAN: 27.51 (-0.09), YORW: 21.87 (-0.29), SYK: 88.84 (+0.26), ECL: 112.95 (-0.03), AXS: 49.64 (+0.31), WHG: 63.75 (-0.37), JJSF: 104.29 (-0.04), AROW: 27.18 (-0.26), LECO: 73.95 (-0.65), BRO: 31.90 (-0.13), WABC: 50.05 (-0.92), UBA: 22.08 (+0.07), RGLD: 64.63 (-1.03), ANDE: 54.12 (-0.81), UTMD: 59.27 (-0.69), EIX: 61.68 (-0.72), LG: 50.50 (-0.43), PB: 60.28 (-0.81), VGR: 21.54 (-0.36)

Syngenta's Q3 Sales Rise Y/Y, 2014 Sales Growth Maintained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:59AM CDT
Syngenta AG (SYT), after completing third-quarter 2014, has maintained its full year aggregated sales growth rate of 6%.
BG: 88.75 (+0.24), SYT: 65.25 (+1.54), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

The Andersons Purchases Two Grain Companies in Texas
CNW Group - Fri Oct 17, 8:00AM CDT
The Andersons, Inc. (Nasdaq: ANDE) announces today it has finalized its purchase of the majority of the assets of two San Antonio, Texas-based, food grade corn companies, United Grain, LLC and Keller Grain, Inc.
ANDE: 54.12 (-0.81)

Andersons (ANDE) Buys Assets of Auburn Bean and Grain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 11:20AM CDT
Andersons (ANDE) has acquired the assets of Auburn Bean and Grain.
BG: 88.75 (+0.24), CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...